Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Ehab R. Bendas"'
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 10, Iss 1, Pp 1-13 (2024)
Abstract Background Neonatal hyperbilirubinemia is a prevalent condition that affects newborns, characterized by elevated serum bilirubin levels. The accumulation of bilirubin can cause neurotoxicity, resulting in various complications, and in severe
Externí odkaz:
https://doaj.org/article/a5174c45af5244809f262bcbb3a083e3
Publikováno v:
Drug Delivery, Vol 29, Iss 1, Pp 3340-3357 (2022)
The anti-hyperglycemic sodium glucose co-transporter 2 inhibitor Canagliflozin (CFZ) represents a recent antihyperglycemic modality, yet it suffers from low oral bioavailability. The current work aims to formulate CFZ-loaded transdermal nanostructure
Externí odkaz:
https://doaj.org/article/6800e29690f8437ca989e328a4a52362
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 8, Iss 1, Pp 1-11 (2022)
Abstract Background Nanotechnology is considered a new and rapidly emerging area in the pharmaceutical and medicinal field. Nanoparticles, as drug delivery systems, impart several advantages concerning improved efficacy as well as reduced adverse dru
Externí odkaz:
https://doaj.org/article/f4955104dd8b4ead969bd2e33df12445
Publikováno v:
Journal of Advanced Research, Vol 15, Iss , Pp 37-47 (2019)
Repeated dose medication usually maximizes adverse effects, while sustained release systems did not offer a fast onset of action. Etodolac was formulated to enable pulsatile and sustained drug release, which was chronologically more suitable as an an
Externí odkaz:
https://doaj.org/article/7bc776764d9843aab394bb23ec739f6f
Autor:
Shaimaa El-Housiny, Maii Atef Shams Eldeen, Yasmina Ahmed El-Attar, Hoda A. Salem, Dalia Attia, Ehab R. Bendas, Mohamed A. El-Nabarawi
Publikováno v:
Drug Delivery, Vol 25, Iss 1, Pp 78-90 (2018)
Solid lipid nanoparticles (SLNs) are very potential formulations for topical delivery of antifungal drugs. Hence, the purpose of this research was to formulate the well-known antifungal agent Fluconazole (FLZ)-loaded SLNs topical gel to improve its e
Externí odkaz:
https://doaj.org/article/c8f133736ad84bf090da7dc654d0e8e5
Publikováno v:
Drug Research.
Favipiravir is an antiviral drug used to treat influenza and is also being investigated for the treatment of SARS-CoV-2. Its pharmacokinetic profile varies depending on ethnic group. The present research examines the pharmacokinetic features of favip
Publikováno v:
Clinical Drug Investigation. 38:439-448
The purpose of this study was to apply the reference-scaled average bioequivalence (RSABE) approach to evaluate the bioequivalence and to investigate the pharmacokinetic properties of two formulations of fixed dose combination (FDC) tablet of sofosbu
Autor:
Ehab R. Bendas, Mohamed A. El-Nabarawi, Yasmina Ahmed El-Attar, Hoda A Salem, Shaimaa El-Housiny, Dalia A. Attia, Maii Atef Shams Eldeen
Publikováno v:
Drug Delivery, Vol 25, Iss 1, Pp 78-90 (2018)
Drug Delivery
Drug Delivery
Solid lipid nanoparticles (SLNs) are very potential formulations for topical delivery of antifungal drugs. Hence, the purpose of this research was to formulate the well-known antifungal agent Fluconazole (FLZ)-loaded SLNs topical gel to improve its e
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 128:61-66
A rapid and sensitive UPLC-MS/MS method was developed and validated for determination of daclatasvir (DAC) in human plasma using sofosbuvir (SOF) as an internal standard (IS). The Xevo TQD LC-MS/MS was operated under the multiple-reaction monitoring
Publikováno v:
Journal of Drug Delivery Science and Technology. 59:101941
This work aims to develop and evaluate buoyant beads embedded with domperidone/Dowex 50WX2 resinate complex as novel multiple-unit type oral gastro-retentive drug delivery system. Domperidone (BCS II) has been chosen for gastric retention as it has a